Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology company Novogen has announced a collaboration agreement to develop new cosmetic applications. The finished products will be manufactured and distributed by a leading cosmetics company, worldwide.
Subscribe to our email newsletter
The partnership matches Novogen’s focus on the identification, preparation, analysis and production of compounds with a leading global beauty company.
According to Novogen, a number of its compounds have the potential in various cosmetic applications. Novogen’s patent position is an added benefit to the cosmetics industry at large. Novogen retains full rights to wound care applications, treatment of burned tissue, hair growth treatments, prescription treatment of skin diseases or skin cancer, injectables of antidote formulations, or trans-dermal delivery of pharmaceutical formulations.
Christopher Naughton, CEO of Novogen, said, “We are proud to be part of the vision, research, and dedication of the cosmetics industry to skin care and look forward to a fruitful partnership.”